Jorn C. Goet

Jorn C. Goet

Auto-generated profile, based on publicly available information

Jorn C. Goet

Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2021 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
EVElsemieke de Vries
Elsemieke de Vries
RBRuth Bolier
Ruth Bolier
JGJorn Goet
Jorn Goet
APAlbert Parés
Albert Parés
JVJef Verbeek
Jef Verbeek
UBUlrich Beuers
Ulrich Beuers

1 January 2019 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
Aldo J. Montano-LozaAldo J. Montano-Loza
Aldo J. Montano-Loza
BHBettina Hansen
Bettina Hansen
CCChristophe Corpechot
Christophe Corpechot
DRDavide Roccarina
Davide Roccarina
DTDouglas Thorburn
Douglas Thorburn
AMAndrew Mason
Andrew Mason

6 April 2018 in Hepatology
Verified
Journal Article
Closed access
PDF file
CPCarla F. Murillo Perez
Carla F. Murillo Perez
JGJorn C. Goet
Jorn C. Goet
WLWillem J. Lammers
Willem J. Lammers
AGAliya Gulamhusein
Aliya Gulamhusein
HBHenk R. van Buuren
Henk R. van Buuren
OGon behalf of the GLOBAL PBC Study Group
on behalf of the GLOBAL PBC Study Group

1 March 2020 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Closed access
NGNikolaos K Gatselis
Nikolaos K Gatselis
JGJorn C. Goet
Jorn C. Goet
KZKalliopi Zachou
Kalliopi Zachou
WLWillem J. Lammers
Willem J. Lammers
HJHarry L.A. Janssen
Harry L.A. Janssen
GDGeorge N. Dalekos
George N. Dalekos

1 November 2019 in Journal of Hepatology
Verified
Journal Article
Closed access
JGJorn C. Goet
Jorn C. Goet
AFAnnarosa Floreani
Annarosa Floreani
Xavier VerhelstXavier Verhelst
Xavier Verhelst
NCNora Cazzagon
Nora Cazzagon
LPLisa Perini
Lisa Perini
BHBettina E. Hansen
Bettina E. Hansen

14 December 2022 in American Journal of Gastroenterology
Verified
Journal Article
Open access
RVRozanne C. de Veer
Rozanne C. de Veer
MHMaria van Hooff
Maria van Hooff
CCChristophe Corpechot
Christophe Corpechot
DTDouglas Thorburn
Douglas Thorburn
PIPietro Invernizzi
Pietro Invernizzi
Adriaan J. van der MeerAdriaan J. van der Meer
Adriaan J. van der Meer
INTRODUCTION: Treatment of primary biliary cholangitis (PBC) can improve the GLOBE score. We aimed to assess the association between changes in the GLOBE score (ΔGLOBE) and liver transplantation (LT)–free survival in patients with PBC who were treated with ursodeoxycholic acid (UDCA). METHODS: Among UDCA-treated patients within the Global PBC cohort, the association between ΔGLOBE (ΔGLOBE 0–1 : during the first year of UDCA, ΔGLOBE 1–2 : during the second year) and the risk of LT or death was assessed through Cox regression analyses. RESULTS: Overall, 3,775 UDCA-treated patients were included; 3,424 (90.7%) were female, the median age was 54.0 (interquartile range [IQR] 45.9–62.4) years, and the median baseline GLOBE score was 0.25 (IQR −0.47 to 0.96). During a median follow-up of 7.2 (IQR 3.7–11.5) years, 730 patients reached the combined end point of LT or death. The median ΔGLOBE 0–1 was −0.27 (IQR −0.56 to 0.02). Cox regression analyses, adjusted for pretreatment GLOBE score and ΔGLOBE 0–1 2 , showed that ΔGLOBE was associated with LT or death (adjusted hazard ratio 2.28, 95% confidence interval 1.81–2.87, P < 0.001). The interaction between baseline GLOBE score and ΔGLOBE 0–1 was not statistically significant ( P = 0.296). The ΔGLOBE 1–2 was associated with LT or death (adjusted hazard ratio 2.19, 95% confidence interval 1.67–2.86, P < 0.001), independently from the baseline GLOBE score and the change in GLOBE score during the first year of UDCA. DISCUSSION: UDCA-induced changes in the GLOBE score were significantly associated with LT-free survival in patients with PBC. While the relative risk reduction of LT or death was stable, the absolute risk reduction was heavily dependent on the baseline prognosis of the patient.